Europe's pharmaceuticals contract manufacturing market is poised to grow in 2020. Active pharmaceutical ingredients (APIs) hold the highest market share, while the final dosage form is estimated to be the top growing segment next year.

Industrial Info is tracking more than 175 pharmaceutical contract manufacturing organization (CMO) projects worth $1.37 Billion in Europe.

By total investment value, the top three projects are:

• Jena Sterile Dosage Forms & Injectables CMO Plant Expansion worth $111,300,000
• Dundalk Grassroot CMO Bulk Biological Substance Plant (Mfg 6 & 7) Phase I worth $100,000,000, and
• Latina Scalo Oncological Immunotherapy Parenterals CMO Expansion Phase I worth $89,020,000.